Cover Image
市場調查報告書

研究及體外診斷用途(質譜分析、層析法、微陣列、電泳、免疫檢測等)支援蛋白質體學的全球市場

Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, & Other Technologies)

出版商 Kalorama Information 商品編碼 314227
出版日期 內容資訊 英文 461 Pages
訂單完成後即時交付
價格
Back to Top
研究及體外診斷用途(質譜分析、層析法、微陣列、電泳、免疫檢測等)支援蛋白質體學的全球市場 Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, & Other Technologies)
出版日期: 2014年09月04日 內容資訊: 英文 461 Pages
簡介

蛋白質體學是蛋白質的研究,包含蛋白質結構和功能,相互作用,表現的蛋白質的鑑定,表現時間和地點相關的研究。蛋白質體學是著重研究市場的廣泛領域,不過另一方面,也能利用於治療學和診斷學。

本報告以研究及體外診斷使用的蛋白質體學的全球市場為焦點,提供其技術、用途概要探索,以及今後至2018年期間的市場變化、產業趨勢和發展的影響要素、課題、地區分析、競爭環境、主要加入企業等相關最新資訊彙整。

第1章 摘要整理

  • 概要
  • 調查的範圍與方法
  • 市場概況
  • 蛋白質體學市場未來發展預測

第2章 簡介

  • 蛋白質體學
  • 人類蛋白質體學計劃和人類蛋白質組機構
  • 觀點

第3章 技術

  • 質譜分析
  • 概要
  • 商業化質譜分析平台及相關產品的企業
  • 活用獨有蛋白質體學技術進行質譜分析的企業
  • 在臨床檢驗室的質譜分析
  • 層析法
  • 液體層析法(LC)和高性能液體層析法(HPLC)概要
  • 其他形式的層析法
  • 微陣列
  • 微流體工程
  • 電泳
  • 凝膠電泳
  • 毛細管電泳法
  • 免疫檢測(抗體的蛋白質捕獲)
  • 生物資訊學

第4章 蛋白質體學的應用領域

  • 研究及生物標記檢測、藥物研發及藥物開發
  • 體外診斷

第5章 蛋白質體學企業的投資及資金提供契約

  • 其他公司之間的契約
  • 蛋白質體學企業的收購
  • 主要的其他契約法

第6章 產業聯合體

  • Worldwide Protein Data Bank (wwPDB)
  • neXtProt
  • PeptideAtlas
  • Protein Identification Database (PRIDE)
  • ProteomeXchange
  • The Human Protein Atlas
  • UniProt Consortium and UniProtKB
  • The Biomarkers Consortium
  • Biomarkers Research Initiatives in Mass Spectometry (BRIMS)
  • Clinical Proteomic Tumor Analysis Consortium (CPTAC)
  • Critical Path Initiative and Predictive Safety Testing Consortium
  • Early Detection Research Network (EDRN)
  • National Biomarker Development Alliance (NBDA)
  • Geneva Bioinformatics (GeneBio) SA and Swiss Institute of Bioinformatics (SIB)

第7章 課題與趨勢

  • 蛋白質體學市場推動要素
  • 鎖定研究市場的蛋白質體學企業面臨的課題與障礙
  • 體外診斷市場上企業面臨的課題與障礙
  • 市場分析

第8章 蛋白質體學的工具和銷售還有平台開發的企業

目錄
Product Code: KLI5321482

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on research markets but has applications in therapeutics and diagnostics.

Proteomics Markets for Research and IVD Applications reflects Kalorama's market estimates, forecasts and competitive analysis of this important are. As part of its coverage, this report includes the following important data:

  • Proteomics Technologies, including: Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Bioinformatics, and Others, plus Discussion of Companies Commercializing Platforms Enabling Others to Use These Technologies
  • Applications of Proteomics, including: Research and Biomarker discovery, Drug Discovery and Development, and in Vitro Diagnostics (IVD)
  • Deals made by Proteomics Companies: Mergers, Partnerships, Investments
  • Consortia and Alliances in Proteomics
  • Proteomics Sales by Geographical Region, Worldwide, (North America, Europe, Asia, ROW)
  • Market Issues and Opportunities, Including Market Drivers for Immunoassays
  • Market Estimates for Mass Spectrometry in Proteomics and Forecast to 2018
  • Market Estimates for Chromatography in Proteomics and Forecast to 2018
  • Market Estimates for Microarrays in Proteomics and Forecast to 2018
  • Market Estimates for Electrophoresis in Proteomics and Forecast to 2018
  • Market Estimates for Immunoassays in Proteomics and Forecast to 2018
  • Market Estimates for IVD Applications of Proteomics
  • Market Estimates for Research Applications of Proteomics
  • Extensive Profiles of Companies
  • Product and Service Market Opportunity for Proteomics

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Understanding the human proteome is a much larger and more challenging task than the Human Genome Project was. The proteome is much more complex as it can change based on factors that affect which genes are expressed. Also, after proteins are expressed, proteins may be modified. Proteomics will remain a very active area of research for several years, and the knowledge derived from this research is expected to produce advances in the diagnosis and treatment of diseases.r decades, many advances are being made in this field. Other major technology segments include chromatography, electrophoresis, microarrays, and other technologies.

Companies discussed in this report include those who with proteomics platforms and related products, commercializing technologies such as mass spectrometry or other proteomics technologies. In addition, this report discusses the proteomics research, services, and products developed and marketed by companies using these proteomics technologies and platforms. Many of the companies in this second group have developed their own proprietary proteomic technologies that utilize technologies such as mass spectrometry or other proteomic technologies.

Companies profiled in this report include:

  • Abbott Laboratories
  • AB SCIEX (A Danaher Corporation Company)
  • ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
  • Advion, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies Inc.
  • Arbor Vita Corporation
  • ArcDia International Oy Ltd
  • Arrayit Corporation
  • Atonomics A/S
  • Avant Diagnostics, Inc.
  • Axela, Inc.
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Banyan Biomarkers
  • Beckman Coulter, Inc.
  • (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BG Medicine, Inc.
  • BioAnalyte Inc.
  • Biocartis SA
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • BioMosaics Inc.
  • Bioproximity, LLC
  • Bio-Rad Laboratories, Inc.
  • Biosensia Ltd.
  • BioSystems International
  • Bruker Corporation
  • Cambridge Protein Arrays Ltd.
  • Caprion, Inc.
  • caprotec bioanalytics GmbH
  • CardioGenics Holdings, Inc.
  • CD Diagnostics, Inc.
  • CDI Laboratories
  • Chromsystems Instruments & Chemicals GmbH
  • Clearbridge BioLoc Pte Ltd.
  • Courtagen Life Sciences, Inc.
  • CovalX AG
  • CRELUX GmbH
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • CyVek Inc.
  • Danaher Corporation
  • Dasit Group - Focusing on
  • DECODON GmbH
  • DiAssess Inc.
  • Digilab, Inc.
  • Dualsystems Biotech AG
  • EMD
  • Euroimmun AG
  • Evotec AG
  • Expedeon, Inc.
  • Fluidigm
  • Fujirebio Inc.
  • GE Healthcare Life Sciences
  • Genalyte, Inc.
  • GeneFluidics, Inc.
  • Geneva Bioinformatics (GeneBio) SA
  • GWC Technologies
  • Helena Laboratories
  • Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
  • Hybrigenics SA
  • ImaBiotech SAS
  • Immunexpress Group
  • Immunovia AB
  • InDevR, Inc.
  • Insilicos LLC
  • Integrated Diagnostics, Inc.
  • Integromics S.L.
  • Intuitive Biosciences, Inc.
  • JOEL Ltd.
  • KineMed, Inc.
  • Kinexus
  • LEAP Technologies, Inc.
  • Life Technologies Corporation
  • LSI Medience Corporation
  • Luminex Corporation
  • MagArray Inc.
  • Matrix Science Limited
  • MBio Diagnostics, Inc.
  • Microlytic ApS
  • QuantiScientifics, LLC
  • Quidel Corporation
  • Rigaku Reagents, Inc.
  • Roche Diagnostics
  • Sebia, Inc.
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Singulex, Inc.
  • SISCAPA Assay Technologies, Inc.
  • SomaLogic, Inc.
  • SpOtOn Clinical Diagnostics Limited
  • SQI Diagnostics Inc.
  • STAT-Diagnostica
  • Syngene (Division of Synoptics Ltd)
  • T2 Biosystems, Inc.
  • Tecan Group AG
  • The Binding Site Group Ltd.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
  • Wako Diagnostics
  • Waters Corporation

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Overview
  • Scope and Methodology
  • Market Overview
  • Future Prospects for the Proteomics Market

CHAPTER TWO: INTRODUCTION

  • Proteomics
  • Human Proteomics Project and Human Proteome Organization
  • Point of View

CHAPTER THREE: TECHNOLOGIES

  • Mass Spectrometry
  • Overview
  • Companies Marketing Mass Spectrometry Platforms and Related Products
  • Companies Utilizing Mass Spectrometry in Proprietary Proteomics Technology
  • Mass Spectrometry in the Clinical Laboratory
  • Chromatography
  • Liquid Chromatography (LC) and High Performance Liquid Chromatography (HPLC) Overview
  • Other Types of Chromatography
  • Microarrays
  • Microfluidics
  • Electrophoresis
  • Gel Electrophoresis
  • Capillary Electrophoresis
  • Immunoassays (Protein Capture by Antibodies)
  • Bioinformatics

CHAPTER FOUR: PROTEOMICS APPLICATIONS

  • Research and Biomarker Discovery, Drug Discovery and Development
  • In Vitro Diagnostics

CHAPTER FIVE: INVESTMENTS AND FINANCING AGREEMENTS FOR PROTEOMICS COMPANIES

  • Agreements Between with Other Companies
  • Acquisitions of Proteomics Companies
  • Selected Other Agreements

CHAPTER SIX: CONSORTIA

  • Worldwide Protein Data Bank (wwPDB)
  • neXtProt
  • PeptideAtlas
  • Protein Identification Database (PRIDE)
  • ProteomeXchange
  • The Human Protein Atlas
  • UniProt Consortium and UniProtKB
  • The Biomarkers Consortium
  • Biomarkers Research Initiatives in Mass Spectometry (BRIMS)
  • Clinical Proteomic Tumor Analysis Consortium (CPTAC)
  • Critical Path Initiative and
  • Predictive Safety Testing Consortium
  • Early Detection Research Network (EDRN)
  • National Biomarker Development Alliance (NBDA)
  • Geneva Bioinformatics (GeneBio) SA and Swiss Institute of Bioinformatics (SIB)

CHAPTER SEVEN: ISSUES AND TRENDS

  • Proteomics Market Drivers
  • Issues and Hurdles Faced by Proteomics Companies Targeting Research Markets
  • Issues and Hurdles Faced by Companies in the in vitro Diagnostics Market
  • Future Prospects

CHAPTER EIGHT: MARKET ANALYSIS

  • Proteomics Product Market Segments by Type of Technology

CHAPTER NINE: COMPANIES MARKETING OR DEVELOPING PROTEOMICS TOOLS AND PLATFORMS

  • Abbott Laboratories
  • AB SCIEX (A Danaher Corporation Company)
  • ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
  • Advion, Inc.
  • Affymetrix, Inc.
  • Arbor Vita Corporation
  • ArcDia International Oy Ltd
  • Arrayit Corporation
  • Atonomics A/S
  • Avant Diagnostics, Inc.
  • Axela, Inc.
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Banyan Biomarkers
  • Beckman Coulter, Inc.
  • (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BG Medicine, Inc.
  • BioAnalyte Inc.
  • Biocartis SA
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • BioMosaics Inc.
  • Bioproximity, LLC
  • Bio-Rad Laboratories, Inc.
  • Biosensia Ltd.
  • BioSystems International
  • Bruker Corporation
  • Cambridge Protein Arrays Ltd.
  • Caprion, Inc.
  • caprotec bioanalytics GmbH
  • CardioGenics Holdings, Inc.
  • CD Diagnostics, Inc.
  • CDI Laboratories
  • Chromsystems Instruments & Chemicals GmbH
  • Clearbridge BioLoc Pte Ltd.
  • Courtagen Life Sciences, Inc.
  • CovalX AG
  • CRELUX GmbH
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • CyVek Inc.
  • Danaher Corporation
  • Dasit Group - Focusing on
  • DECODON GmbH
  • DiAssess Inc.
  • Digilab, Inc.
  • Dualsystems Biotech AG
  • EMD
  • Euroimmun AG
  • Evotec AG
  • Expedeon, Inc.
  • Fluidigm
  • Fujirebio Inc.
  • GE Healthcare Life Sciences
  • Genalyte, Inc.
  • GeneFluidics, Inc.
  • Geneva Bioinformatics (GeneBio) SA
  • GWC Technologies
  • Helena Laboratories
  • Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
  • Hybrigenics SA
  • ImaBiotech SAS
  • Immunexpress Group
  • Immunovia AB
  • InDevR, Inc.
  • Insilicos LLC
  • Integrated Diagnostics, Inc.
  • Integromics S.L.
  • Intuitive Biosciences, Inc.
  • JOEL Ltd.
  • KineMed, Inc.
  • Kinexus
  • LEAP Technologies, Inc.
  • Life Technologies Corporation
  • LSI Medience Corporation
  • Luminex Corporation
  • MagArray Inc.
  • Matrix Science Limited
  • MBio Diagnostics, Inc.
  • Microlytic ApS
  • QuantiScientifics, LLC
  • Quidel Corporation
  • Rigaku Reagents, Inc.
  • Roche Diagnostics
  • Sebia, Inc.
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Singulex, Inc.
  • SISCAPA Assay Technologies, Inc.
  • SomaLogic, Inc.
  • SpOtOn Clinical Diagnostics Limited
  • SQI Diagnostics Inc.
  • STAT-Diagnostica
  • Syngene (Division of Synoptics Ltd)
  • T2 Biosystems, Inc.
  • Tecan Group AG
  • The Binding Site Group Ltd.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
  • Wako Diagnostics
  • Waters Corporation
Back to Top